Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche, Merck to Develop Tests for Merck’ Cancer Therapies
Bloomberg
Tuesday, June 7, 2011 - 9:51am
tags:
Roche, Merck, cancer
Glaxo, Crucell, PATH Malaria in Pact to Develop Malaria Vaccine
Bloomberg
Tuesday, June 7, 2011 - 9:50am
tags:
GSK, Crucell, vaccines, malaria
AstraZeneca Pays $250K For Sex Discrimination
Pharmalot
Monday, June 6, 2011 - 9:35pm
tags:
gender discrimination, AstraZeneca
Gen-Probe Shares Tumble on Report Novartis May Not Bid
Bloomberg
Monday, June 6, 2011 - 9:34pm
tags:
Gen-Probe, Novartis, M&A
Corcept Therapeutics details Corlux study results
Yahoo/AP
Monday, June 6, 2011 - 9:33pm
tags:
Corcept Therapeutics, Corlux, Cushing's syndrome
Repligen Earnings Preview
Motley Fool
Monday, June 6, 2011 - 9:32pm
tags:
earnings, Repligen
ASCO '11: Exelixis Updates Prostate Cancer Data
TheStreet.com
Monday, June 6, 2011 - 9:28pm
tags:
Exelixis, prostate cancer, ASCO, cabozantinib
Weekend at ASCO: Drugs for Skin, Lung, Ovarian Cancer
WSJ Online
Monday, June 6, 2011 - 9:27pm
tags:
ASCO, melanoma, ovarian cancer, lung cancer, Pfizer, crizotinib, vemurafenib, JNJ, prostate cancer, Roche, Avastin, Zytiga
Algeta shares spike on promising prostate cancer drug data
Fierce Biotech
Monday, June 6, 2011 - 12:34pm
tags:
Algeta, prostate cancer, Apharadin
With promising Ph3 data in hand, Incyte files for myelofibrosis drug OK
Fierce Biotech
Monday, June 6, 2011 - 12:31pm
tags:
Incyte, myelofibrosis, ruxolitinib
Novartis Likely Buyer for Gen-Probe
WSJ Online
Monday, June 6, 2011 - 12:29pm
tags:
Gen-Probe, M&A, Novartis
BioSante Says FDA Lifts Clinical Hold On GVAX Prostate Cancer Vaccine; Shares Up
RTT News
Monday, June 6, 2011 - 11:17am
tags:
BioSante, FDA, vaccines, prostate cancer, GVAX
Dr Reddy's Laboratories Launches 3 Generic Drugs In US
WSJ Online
Monday, June 6, 2011 - 11:11am
tags:
generics, Dr Reddy's, India, Effexor XR, Aricept, Femara
Teva reports positive Phase III blood disease trial results
Globes, Israel
Monday, June 6, 2011 - 11:10am
tags:
Teva Pharmaceuticals, lipegfilgrastim, neutropenia
Sunesis tumbles 16% in early trading
Marketwatch
Monday, June 6, 2011 - 11:08am
tags:
Sunesis, vosaroxin, acute myeloid leukemia
A Quick Roundup Of The New Drugs Presented At This Weekend's Huge Oncology Conference
Yahoo/Business Insider
Monday, June 6, 2011 - 10:25am
tags:
ASCO, Amgen, Aveo Pharmaceutical, Celgene, Medivation, tivozanib, abiraterone, Abraxane, AMG 479, Revlimid
Amylin says drug helped metabolic disease symptoms
Yahoo/AP
Monday, June 6, 2011 - 10:22am
tags:
Amylin, metreliptin, lipodystrophy
Oxigene soars on Nasdaq update
Marketwatch
Monday, June 6, 2011 - 10:20am
tags:
Oxigene, NASDAQ
Roche's vemurafenib plays a starring role at ASCO
Fierce Biotech
Monday, June 6, 2011 - 9:36am
tags:
Roche, ASCO, vemurafenib, Plexxikon, melanoma
10 Reasons to Buy Teva Pharmaceuticals
Seeking Alpha
Monday, June 6, 2011 - 9:27am
tags:
Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.